These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 30755077)

  • 1. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications.
    Saleem Z; Hassali MA; Versporten A; Godman B; Hashmi FK; Goossens H; Saleem F
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):285-293. PubMed ID: 30755077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point Prevalence Survey of Antimicrobial Prescribing in a Nigerian Hospital: Findings and Implications on Antimicrobial Resistance.
    Fowotade A; Fasuyi T; Aigbovo O; Versporten A; Adekanmbi O; Akinyemi O; Goossens H; Kehinde A; Oduyebo O
    West Afr J Med; 2020; 37(3):216-220. PubMed ID: 32476113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey.
    Labi AK; Obeng-Nkrumah N; Nartey ET; Bjerrum S; Adu-Aryee NA; Ofori-Adjei YA; Yawson AE; Newman MJ
    Antimicrob Resist Infect Control; 2018; 7():15. PubMed ID: 29423190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey.
    Abubakar U
    BMC Infect Dis; 2020 Jan; 20(1):86. PubMed ID: 32000722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications.
    Anand Paramadhas BD; Tiroyakgosi C; Mpinda-Joseph P; Morokotso M; Matome M; Sinkala F; Gaolebe M; Malone B; Molosiwa E; Shanmugam MG; Raseatlholo GP; Masilo J; Oyeniran Y; Marumoloa S; Maakelo OG; Katjakae I; Kgatlwane J; Godman B; Massele A
    Expert Rev Anti Infect Ther; 2019 Jul; 17(7):535-546. PubMed ID: 31257952
    [No Abstract]   [Full Text] [Related]  

  • 6. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016.
    Al Matar M; Enani M; Binsaleh G; Roushdy H; Alokaili D; Al Bannai A; Khidir Y; Al-Abdely H
    J Infect Public Health; 2019; 12(1):77-82. PubMed ID: 30270148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global point prevalence survey of antimicrobial consumption in Brazilian hospitals.
    Porto APM; Goossens H; Versporten A; Costa SF;
    J Hosp Infect; 2020 Feb; 104(2):165-171. PubMed ID: 31678430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications.
    Saleem Z; Hassali MA; Hashmi FK; Godman B; Bhutta OA
    Hosp Pract (1995); 2019 Aug; 47(3):149-154. PubMed ID: 31180791
    [No Abstract]   [Full Text] [Related]  

  • 9. The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.
    German GJ; Frenette C; Caissy JA; Grant J; Lefebvre MA; Mertz D; Lutes S; McGeer A; Roberts J; Afra K; Valiquette L; Émond Y; Carrier M; Lauzon-Laurin A; Nguyen TT; Al-Bachari H; Kosar J; Peermohamed S; Science M; Landry D; MacLaggan T; Daley P; McDonald G; Ang A; Chang S; Lin YC; Tong B; Malfair S; Leung V; Katz K; Pauwels I; Goossens H; Versporten A; Conly J; Thirion DJG
    CMAJ Open; 2021; 9(4):E1242-E1251. PubMed ID: 34933882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
    Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
    BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan.
    Elhajji FD; Al-Taani GM; Anani L; Al-Masri S; Abdalaziz H; Qabba'h SH; Al Bawab AQ; Scott M; Farren D; Gilmore F; Versporten A; Goossens H; Aldeyab MA
    BMC Health Serv Res; 2018 Nov; 18(1):849. PubMed ID: 30419895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications.
    Saleem Z; Haseeb A; Godman B; Batool N; Altaf U; Ahsan U; Khan FU; Mustafa ZU; Nadeem MU; Farrukh MJ; Mugheera M; Rehman IU; Khan AF; Saeed H; Hossain MA; Raafat M; Radwan RM; Iqbal MS
    Antibiotics (Basel); 2022 Dec; 12(1):. PubMed ID: 36671271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Plachouras D; Kärki T; Hansen S; Hopkins S; Lyytikäinen O; Moro ML; Reilly J; Zarb P; Zingg W; Kinross P; Weist K; Monnet DL; Suetens C;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan regional government of Northern Iraq: the need for urgent action.
    Kurdi A; Hasan AJ; Baker KI; Seaton RA; Ramzi ZS; Sneddon J; Godman B
    Expert Rev Anti Infect Ther; 2021 Jun; 19(6):805-814. PubMed ID: 33034234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Healthcare-Associated Infections and Antimicrobial Use Among Adult Inpatients in Singapore Acute-Care Hospitals: Results From the First National Point Prevalence Survey.
    Cai Y; Venkatachalam I; Tee NW; Tan TY; Kurup A; Wong SY; Low CY; Wang Y; Lee W; Liew YX; Ang B; Lye DC; Chow A; Ling ML; Oh HM; Cuvin CA; Ooi ST; Pada SK; Lim CH; Tan JWC; Chew KL; Nguyen VH; Fisher DA; Goossens H; Kwa AL; Tambyah PA; Hsu LY; Marimuthu K
    Clin Infect Dis; 2017 May; 64(suppl_2):S61-S67. PubMed ID: 28475790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey.
    Labi AK; Obeng-Nkrumah N; Sunkwa-Mills G; Bediako-Bowan A; Akufo C; Bjerrum S; Owusu E; Enweronu-Laryea C; Opintan JA; Kurtzhals JAL; Newman MJ
    BMC Pediatr; 2018 Dec; 18(1):391. PubMed ID: 30572851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications.
    Saleem Z; Saeed H; Hassali MA; Godman B; Asif U; Yousaf M; Ahmed Z; Riaz H; Raza SA
    Antimicrob Resist Infect Control; 2019; 8():188. PubMed ID: 31768252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare-associated infections and antimicrobial use in acute care hospitals in Greece, 2022; results of the third point prevalence survey.
    Palaiopanos K; Krystallaki D; Mellou K; Kotoulas P; Kavakioti CA; Vorre S; Vertsioti G; Gkova M; Maragkos A; Tryfinopoulou K; Paraskevis D; Tsiodras S; Zaoutis T
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):11. PubMed ID: 38273402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
    Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
    Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.